Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model

American Journal of Pathology

Volumn 171, Issue 4, 2007, Pages 1304-1311

  Spires Jones, Tara L ^a   Meyer Luehmann, Melanie ^a   Osetek, Jennifer D ^a   Jones, Phillip B ^a   Stern, Edward A ^a   Bacskai, Brian J ^a   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DISEASE SEVERITY; IN VIVO STUDY; MOUSE; MULTIPHOTON MICROSCOPY; NERVE CELL PLASTICITY; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; SPINE DISEASE; SPINE STABILIZATION;

EID: 35348904351     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070055     Document Type: Article

References (52)

1. Hyman BT, Van Horsen GW, Damasio AR, Barnes CL: Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984, 225:1168-1170
2. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991, 82:239-259
3. Spires TL, Hyman BT: Neuronal structure is altered by amyloid plaques. Rev Neurosci 2004, 15:267-278
4. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R: Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991, 30:572-580
5. DeKosky ST, Scheff SW, Styren SD: Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 1996, 5:417-421
6. Masliah E, Mallory M, Hansen L, DeTeresa R, Alford M, Terry R: Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci Lett 1994, 174:67-72
7. Coleman PD, Yao PJ: Synaptic slaughter in Alzheimer's disease. Neurobiol Aging 2003, 24:1023-1027
8. Harris KM: Structure, development, and plasticity of dendritic spines. Curr Opin Neurobiol 1999, 9:343-348
9. Matus A: Growth of dendritic spines: a continuing story. Curr Opin Neurobiol 2005, 15:67-72
10. Majewska A, Sur M: Motility of dendritic spines in visual cortex in vivo: changes during the critical period and effects of visual deprivation. Proc Natl Acad Sci USA 2003, 100:16024-16029
11. Matus A: Actin-based plasticity in dendritic spines. Science 2000, 290:754-758
12. Lendvai B, Stern EA, Chen B, Svoboda K: Experience-dependent plasticity of dendritic spines in the developing rat barrel cortex in vivo. Nature 2000, 404:876-881
13. Stern EA, Maravall M, Svoboda K: Rapid development and plasticity of layer 2/3 maps in rat barrel cortex in vivo. Neuron 2001, 31:305-315
14. Holtmaat AJ, Trachtenberg JT, Wilbrecht L, Shepherd GM, Zhang X, Knott GW, Svoboda K: Transient and persistent dendritic spines in the neocortex in vivo. Neuron 2005, 45:279-291
15. Trachtenberg JT, Chen BE, Knott GW, Feng G, Sanes JR, Welker E, Svoboda K: Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 2002, 420:788-794
16. Fiala JC, Spacek J, Harris KM: Dendritic spine pathology: cause or consequence of neurological disorders? Brain Res Brain Res Rev 2002, 39:29-54
17. Catala I, Ferrer I, Galofre E, Fabregues I: Decreased numbers of dendritic spines on cortical pyramidal neurons in dementia. A quantitative Golgi study on biopsy samples. Hum Neurobiol 1988, 6:255-259
18. Davies CA, Mann DM, Sumpter PQ, Yates PO: A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 1987, 78:151-164
19. de Ruiter JP, Uylings HB: Morphometric and dendritic analysis of fascia dentata granule cells in human aging and senile dementia. Brain Res 1987, 402:217-229
20. Selkoe DJ: Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid β-protein. Ann NY Acad Sci 2000, 924:17-25
21. Lanz TA, Carter DB, Merchant KM: Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol Dis 2003, 13:246-253
22. Moolman DL, Vitolo OV, Vonsattel JP, Shelanski ML: Dendrite and dendritic spine alterations in Alzheimer models. J Neurocytol 2004, 33:377-387
23. Tsai J, Grutzendler J, Duff K, Gan WB: Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 2004, 7:1181-1183
24. Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT, Bacskai BJ, Hyman BT: Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci 2005, 25:7278-7287
25. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G: Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice Science 1996, 274:99-102
26. Klunk WE, Bacskai BJ, Mathis CA, Kajdasz ST, McLellan ME, Frosch MP, Debnath ML, Holt DP, Wang Y, Hyman BT: Imaging Aβ plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. J Neuropathol Exp Neurol 2002, 61:797-805
27. Bacskai BJ, Kajdasz ST, McLellan ME, Games D, Seubert P, Schenk D, Hyman BT: Non-Fo-mediated mechanisms are involved in clearance of amyloid-β in vivo by immunotherapy. J Neurosci 2002, 22:7873-7878
28. Lombardo JA, Stern EA, McLellan ME, Kajdasz ST, Hickey GA, Bacskai BJ, Hyman BT: Amyloid-β antibody treatment leads to rapid normalization of plaque-induced neuritic alterations. J Neurosci 2003, 23:10879-10883
29. Skoch J, Hickey GA, Kajdasz ST, Hyman BT, Bacskai BJ: In vivo imaging of amyloid-β deposits in mouse brain with multiphoton microscopy. Amyloid proteins: methods and protocols. Edited by EM Sigurdsson. Totowa, Humana Press, 2004, pp 349-364
30. Spires TL, Molnar Z, Kind PC, Cordery PM, Upton AL, Blakemore C, Hannan AJ: Activity-dependent regulation of synapse and dendritic spine morphology in developing barrel cortex requires phospholipase C-β1 signalling. Cereb Cortex 2005, 15:385-393
31. Majewska A, Tashiro A, Yuste R: Regulation of spine calcium dynamics by rapid spine motility. J Neurosci 2000, 20:8262-8268
32. Schubert V, Da Silva JS, Dotti CG: Localized recruitment and activation of RhoA underlies dendritic spine morphology in a glutamate receptor-dependent manner. J Cell Biol 2006, 172:453-467
33. Burke SN, Barnes CA: Neural plasticity in the ageing brain. Nat Rev Neurosci 2006, 7:30-40
34. Zuo Y, Lin A, Chang P, Gan WB: Development of long-term dendritic spine stability in diverse regions of cerebral cortex. Neuron 2005, 46:181-189
35. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH: Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat Neurosci 2005, 8:79-84
36. Almeida CG, Tampellini D, Takahashi RH, Greengard P, Lin MT, Snyder EM, Gouras GK: β-Amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis 2005, 20:187-198
37. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH, Bloom FE: Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2006, 103:5161-5166
38. Stern EA, Bacskai BJ, Hickey GA, Attenello FJ, Lombardo JA, Hyman BT: Cortical synaptic integration in vivo is disrupted by amyloid-β plaques. J Neurosci 2004, 24:4535-4540
39. Knowles RB, Wyart C, Buldyrev SV, Cruz L, Urbanc B, Hasselmo ME, Stanley HE, Hyman BT: Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease. Proc Natl Acad Sci USA 1999, 96:5274-5279
40. Knowles RB, Gomez-Isla T, Hyman BT: Aβ associated neuropil changes: correlation with neuronal loss and dementia. J Neuropathol Exp Neurol 1998, 57:1122-1130
41. D'Amore JD, Kajdasz ST, McLellan ME, Bacskai BJ, Stern EA, Hyman BT: In vivo multiphoton imaging of a transgenic mouse model of Alzheimer disease reveals marked thioflavine-S-associated alterations in neurite trajectories. J Neuropathol Exp Neurol 2003, 62:137-145
42. Dickson TC, Vickers JC: The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience 2001, 105:99-107
43. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL: Synaptic targeting by Alzheimer's-related amyloid β oligomers. J Neurosci 2004, 24:10191-10200
44. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P: Regulation of NMDA receptor trafficking by amyloid-β. Nat Neurosci 2005, 8:1051-1058
45. Roselli F, Tirard M, Lu J, Hutzler P, Lamberti P, Livrea P, Morabito M, Almeida OF: Soluble β-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. J Neurosci 2005, 25:11061-11070
46. Buttini M, Masliah E, Barbour R, Grajeda H, Motter R, Johnson-Wood K, Khan K, Seubert P, Freedman S, Schenk D, Games D: β-Amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease. J Neurosci 2005, 25:9096-9101
47. McLellan ME, Kajdasz ST, Hyman BT, Bacskai BJ: In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. J Neurosci 2003, 23:2212-2217
48. Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC: Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging 2004, 25:663-674
49. Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, Paul SM: Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2000, 97:2892-2897
50. Park JH, Gimbel DA, GrandPre T, Lee J-K, Kim J-E, Li W, Lee DH, Strittmatter SM: Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-β plaque deposition. J Neurosci 2006, 26:1386-1395
51. Schubert V, Dotti CG: Transmitting on actin: synaptic control of dendritic architecture. J Cell Sci 2007, 120:205-212
52. Xu HT, Pan F, Yang G, Gan WB: Choice of cranial window type for in vivo imaging affects dendritic spine turnover in the cortex. Nat Neurosci 2007, 10:549-551